Milestone Pharmaceuticals Inc.

NasdaqGS:MIST 주식 보고서

시가총액: US$121.9m

Milestone Pharmaceuticals 대차 대조표 상태

재무 상태 기준 확인 5/6

Milestone Pharmaceuticals 의 총 주주 지분은 $24.0M 이고 총 부채는 $52.4M, 이는 부채 대 자기자본 비율을 218.4% 로 가져옵니다. 총자산과 총부채는 각각 $82.7M 및 $58.7M 입니다.

주요 정보

218.4%

부채 비율

US$52.43m

부채

이자 보상 비율n/a
현금US$76.42m
주식US$24.01m
총 부채US$58.69m
총 자산US$82.71m

최근 재무 상태 업데이트

Recent updates

Does Milestone Pharmaceuticals (NASDAQ:MIST) Have A Healthy Balance Sheet?

Nov 06
Does Milestone Pharmaceuticals (NASDAQ:MIST) Have A Healthy Balance Sheet?

Here's Why Shareholders Should Examine Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO Compensation Package More Closely

Jun 07
Here's Why Shareholders Should Examine Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO Compensation Package More Closely

Is Milestone Pharmaceuticals (NASDAQ:MIST) A Risky Investment?

Sep 13
Is Milestone Pharmaceuticals (NASDAQ:MIST) A Risky Investment?

We're Keeping An Eye On Milestone Pharmaceuticals' (NASDAQ:MIST) Cash Burn Rate

Mar 07
We're Keeping An Eye On Milestone Pharmaceuticals' (NASDAQ:MIST) Cash Burn Rate

We're Keeping An Eye On Milestone Pharmaceuticals' (NASDAQ:MIST) Cash Burn Rate

Oct 15
We're Keeping An Eye On Milestone Pharmaceuticals' (NASDAQ:MIST) Cash Burn Rate

We Think Milestone Pharmaceuticals (NASDAQ:MIST) Can Afford To Drive Business Growth

Jun 24
We Think Milestone Pharmaceuticals (NASDAQ:MIST) Can Afford To Drive Business Growth

We're Hopeful That Milestone Pharmaceuticals (NASDAQ:MIST) Will Use Its Cash Wisely

Feb 25
We're Hopeful That Milestone Pharmaceuticals (NASDAQ:MIST) Will Use Its Cash Wisely

We're Interested To See How Milestone Pharmaceuticals (NASDAQ:MIST) Uses Its Cash Hoard To Grow

Aug 25
We're Interested To See How Milestone Pharmaceuticals (NASDAQ:MIST) Uses Its Cash Hoard To Grow

Companies Like Milestone Pharmaceuticals (NASDAQ:MIST) Are In A Position To Invest In Growth

Apr 02
Companies Like Milestone Pharmaceuticals (NASDAQ:MIST) Are In A Position To Invest In Growth

What You Need To Know About Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) Investor Composition

Jan 15
What You Need To Know About Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) Investor Composition

First patient enrolled in Milestone Pharmaceuticals' late-stage study of etripamil in PSVT

Nov 18

Milestone Pharmaceuticals EPS beats by $0.09

Nov 13

재무 상태 분석

단기부채: MIST 의 단기 자산 ( $81.0M )이 단기 부채( $5.3M ).

장기 부채: MIST 의 단기 자산( $81.0M )이 장기 부채( $53.4M ).


부채 대 자본 내역 및 분석

부채 수준: MIST 총 부채보다 더 많은 현금을 보유하고 있습니다.

부채 감소: MIST 의 부채 대 자기자본 비율은 지난 5년간 0% 에서 218.4% 로 증가했습니다.


대차 대조표


현금 런웨이 분석

과거에 평균적으로 적자를 기록했던 기업의 경우, 최소 1년 이상의 현금 유동성을 보유하고 있는지 평가합니다.

안정적인 현금 활주로: MIST 현재 무료 현금 흐름을 기준으로 1년 이상 충분한 현금 활주로를 보유하고 있습니다.

예측 현금 활주로: MIST 1.3 1.9 1.3 % 매년.


건강한 기업 발견하기